MedPath
FDA Approval

Docetaxel anhydrous

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 10, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Docetaxel(10 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Docetaxel anhydrous

Product Details

NDC Product Code
71288-144
Application Number
ANDA209634
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
February 22, 2022
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
DocetaxelActive
Code: 699121PHCAClass: ACTIBQuantity: 10 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath